Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Odeberg

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 27, 2002
Novel candidate genes for atherosclerosis are identified by representational difference analysis-based transcript profiling of cholesterol-loaded macrophagesT Andersson, S Boräng, M Larsson, et al.
Veterinary Immunology and Immunopathology|November 1, 1996
PR-39, a proline-rich peptide antibiotic from pig, and FALL-39, a tentative human counterpartB Agerberth, H Gunne, J Odeberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testisB Agerberth, H Gunne, J Odeberg, et al.
Biotechniques|July 1, 1996
Solid-phase method for differential display of genes expressed in hematopoietic stem cellsO Røsok, J Odeberg, M Rode, et al.
Genes and Immunity|January 23, 2004
Both risk alleles for FcgammaRIIA and FcgammaRIIIA are susceptibility factors for SLE: a unifying hypothesisV Magnusson, B Johanneson, G Lima, et al.
Scandinavian Journal of Immunology|March 19, 2002
Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18J Odeberg, C Cerboni, H Browne, et al.
Arthritis and Rheumatism|April 13, 2004
Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish populationV Magnusson, R Zunec, J Odeberg, et al.
Oncogene|October 20, 1998
Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinomaA Ahmadian, Z P Ren, C Williams, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesisA Agren, B Wiman, V Stiller, et al.
Journal of Thrombosis and Haemostasis : JTH|December 5, 2014
Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factorsM Bruzelius, M Bottai, M Sabater-Lleal, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 27, 2002
Novel candidate genes for atherosclerosis are identified by representational difference analysis-based transcript profiling of cholesterol-loaded macrophagesT Andersson, S Boräng, M Larsson, et al.
Veterinary Immunology and Immunopathology|November 1, 1996
PR-39, a proline-rich peptide antibiotic from pig, and FALL-39, a tentative human counterpartB Agerberth, H Gunne, J Odeberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testisB Agerberth, H Gunne, J Odeberg, et al.
Biotechniques|July 1, 1996
Solid-phase method for differential display of genes expressed in hematopoietic stem cellsO Røsok, J Odeberg, M Rode, et al.
Genes and Immunity|January 23, 2004
Both risk alleles for FcgammaRIIA and FcgammaRIIIA are susceptibility factors for SLE: a unifying hypothesisV Magnusson, B Johanneson, G Lima, et al.
Scandinavian Journal of Immunology|March 19, 2002
Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18J Odeberg, C Cerboni, H Browne, et al.
Arthritis and Rheumatism|April 13, 2004
Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish populationV Magnusson, R Zunec, J Odeberg, et al.
Oncogene|October 20, 1998
Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinomaA Ahmadian, Z P Ren, C Williams, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesisA Agren, B Wiman, V Stiller, et al.
Journal of Thrombosis and Haemostasis : JTH|December 5, 2014
Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factorsM Bruzelius, M Bottai, M Sabater-Lleal, et al.
Pageof 4